Education
About Us
Working with TipRanks
Follow Us
Silence Therapeutics (DE:XRP2)
FRANKFURT:XRP2
XRP2 Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
XRP2 Stock 12 Month Forecast
Average Price Target
€31.80
▲(582.37%Upside)
| Highest Price Target€63.60 | Average Price Target€31.80 | Lowest Price Target€12.72 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
William Blair
―
Buy
―
Reiterated
06/13/25
H.C. Wainwright
€64
Buy
1273.34%
Upside
Reiterated
06/13/25
Morgan Stanley
€21.33
Buy
357.78%
Upside
Reiterated
06/12/25
BMO Capital
€12.8
Buy
174.67%
Upside
Reiterated
06/12/25
Chardan Capital
€29.87
Buy
540.89%
Upside
Reiterated
05/09/25
Goldman Sachs
€5.12→€3.41
Sell
-26.76%
Downside
Reiterated
03/04/25
Jefferies
€26.45→€25.6
Buy
449.34%
Upside
Reiterated
02/27/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
William Blair
―
Buy
―
Reiterated
06/13/25
H.C. Wainwright
€64
Buy
1273.34%
Upside
Reiterated
06/13/25
Morgan Stanley
€21.33
Buy
357.78%
Upside
Reiterated
06/12/25
BMO Capital
€12.8
Buy
174.67%
Upside
Reiterated
06/12/25
Chardan Capital
€29.87
Buy
540.89%
Upside
Reiterated
05/09/25
Goldman Sachs
€5.12→€3.41
Sell
-26.76%
Downside
Reiterated
03/04/25
Jefferies
€26.45→€25.6
Buy
449.34%
Upside
Reiterated
02/27/25
Best Analysts Covering Silence Therapeutics
1 Month
xxx
Success Rate
9/13 ratings generated profit
Average Return
+9.12%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of +9.12% per trade.
3 Months
xxx
Success Rate
10/13 ratings generated profit
Average Return
+18.79%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +18.79% per trade.
1 Year
Success Rate
7/13 ratings generated profit
Average Return
-2.78%
reiterated a buy rating 20 days ago
Copying Myles Minter's trades and holding each position for 1 Year would result in 53.85% of your transactions generating a profit, with an average return of -2.78% per trade.
2 Years
xxx
Success Rate
6/15 ratings generated profit
Average Return
-28.16%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -28.16% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
XRP2 Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
May 25
Jun 25
Strong Buy
12
8
7
9
9
Buy
0
1
1
2
2
Hold
0
0
0
0
0
Sell
0
1
2
2
1
Strong Sell
0
0
0
0
0
total
12
10
10
13
12
Each month's total comprises the sum of three months' worth of ratings.
XRP2 Financial Forecast
XRP2 Stock Forecast FAQ
What is DE:XRP2’s average 12-month price target, according to analysts?
Based on analyst ratings, Silence Therapeutics’s 12-month average price target is 31.80.
What is DE:XRP2’s upside potential, based on the analysts’ average price target?
Silence Therapeutics has 582.37% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Silence Therapeutics a Buy, Sell or Hold?
Silence Therapeutics has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Silence Therapeutics’s share price target?
The average share price target for Silence Therapeutics is 31.80. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €63.60 ,and the lowest forecast is €12.72. The average share price target represents 582.37% Increase from the current price of €4.66.
The highest analyst share price target is €63.60 ,and the lowest forecast is €12.72. The average share price target represents 582.37% Increase from the current price of €4.66.
What do analysts say about Silence Therapeutics?
Silence Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of Silence Therapeutics?
To buy shares of DE:XRP2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.